Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction. - Ciancaglini M; Avanthay R; Marx AF; Abreu-Mota T; Finozzi D; Fixemer J; Geier F; Burri D; Wagner I; Vincenti I; Kreuzfeldt M; Merkler D; et al. (Molecular therapy. Nucleic acids, 2026)